- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06294769
Effect of Aromatherapy on Postoperative Pain: Randomized Clinical Trial
December 10, 2024 updated by: Maria Fernanda de Oliveira Faria, University of Sao Paulo
Effect of Aromatherapy on Postoperative Pain in Adult Patients in Post-anesthesics Recovering Room: Randomized Clinical Trial
Introduction: Pain is one of the main complications in the immediate postoperative period that can harm the patient and can be managed through pharmacological and non-pharmacological methods.
Complementary Integrative Health Practices are non-pharmacological methods that use therapeutic resources based on traditional knowledge to treat symptoms.
Among them, aromatherapy stands out, which consists of the use of essential oils through inhalation or topical application for therapeutic purposes and which can be used as a nursing intervention, especially in the context of perioperative care.
Objective: To evaluate the effect of aromatherapy on postoperative pain in adult patients in the immediate postoperative period.
Method: This is a randomized controlled clinical trial that will be carried out in a teaching hospital.
The project was submitted to the Research Ethics Committees of the School of Nursing of the University of Sao Paulo and the University of Sao Paulo Hospital.
Adult patients undergoing elective surgical procedures of any surgical specialty under anesthesia of any type will be included.
Individuals diagnosed with dementia, cognitive impairment or chronic pain will be excluded; individuals with a history of asthma, allergic bronchitis, chronic obstructive pulmonary disease, contact dermatitis or allergy to cosmetics with lavender fragrance, or hypersensitivity to the compounds used in the intervention; procedure for reoperation for any reason.
The intervention will consist of the application of aromatherapy with 2% lavender essential oil through the skin and inhalation by a nurse, associated with usual care, in the immediate postoperative period; the placebo group will only receive the application of grape seed vegetable oil associated with usual care.
A numerical verbal scale will be applied to assess pain and vital parameters will be measured upon patient admission, every fifteen minutes in the first hour and every thirty minutes in the second hour or after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after applying the intervention, in the post-anesthesia recovery room.
Possible associations between variables will be verified using Pearson's Chi-square or Fisher's exact tests.
Comparison between means or medians will be made using the Student's t or Mann-Whitney tests, depending on the normality determined according to the Kolmogorov-Smirnov test.
The significance level adopted will be 5%.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
138
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Paulo, SP, Brazil, 05508-000
- Universidade de São Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- adult patients undergoing elective surgical procedures of any surgical specialty under anesthesia of any type
Exclusion Criteria:
- individuals diagnosed with dementia, cognitive impairment or chronic pain;
- individuals with a history of asthma, allergic bronchitis, chronic obstructive pulmonary disease, contact dermatitis or allergy to cosmetics with lavender fragrance, or hypersensitivity to the compounds used in the intervention;
- procedure for reoperation for any reason
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: 2% lavender essential oil.
Group will receive application of aromatherapy with 2% lavender essential oil dermal and inhalation via by a nurse, associated with usual care, in the immediate postoperative period.
|
The intervention will consist of the application of aromatherapy with 2% lavender essential oil cutaneously and inhalation via by a nurse, associated with usual care, in the immediate postoperative period
|
|
Placebo Comparator: Group 2: grape seed vegetable oil.
Placebo group will only receive the application of grape seed vegetable oil associated with usual care in the post anesthetic recovery room.
|
The placebo group will only receive the application of grape seed vegetable oil associated with usual care in the immediate postoperative period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acute pain
Time Frame: 2 hours
|
A numerical verbal scale (1 to 10) for assessing pain upon patient admission, after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after application intervention, in the post-anesthesia recovery room.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Blood pressure (both systolic and diastolic)
Time Frame: 2 hours
|
Non-invasive blood pressure measurement (in mmHg) upon patient admission, after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after application intervention, in the post-anesthesia recovery room
|
2 hours
|
|
Heart rate
Time Frame: 2 hours
|
Heart rate measurement with multi parameter monitor(in bpm) upon patient admission, after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after application intervention, in the post-anesthesia recovery room
|
2 hours
|
|
Respiratory frequency
Time Frame: 2 hours
|
Respiratory frequency assessment (breathing rate by counting the number of breaths per minute) upon patient admission, after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after application intervention, in the post-anesthesia recovery room
|
2 hours
|
|
Oxygen saturation
Time Frame: 2 hours
|
Oxygen saturation (SpO2) measurement (in percent (%), with a pulse oximeter non-invasive device) upon patient admission, after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after application intervention, in the post-anesthesia recovery room
|
2 hours
|
|
Temperature
Time Frame: 2 hours
|
Temperature assessment (in Celsius scale ) upon patient admission, after 15, 30, 45, 60 minutes, 1h30 minutes and 2 hours after application intervention, in the post-anesthesia recovery room
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 18, 2024
Primary Completion (Actual)
July 31, 2024
Study Completion (Actual)
July 31, 2024
Study Registration Dates
First Submitted
February 14, 2024
First Submitted That Met QC Criteria
March 2, 2024
First Posted (Actual)
March 6, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 10, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 022024 Maria Fernanda
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Pain
-
Rajavithi HospitalCompletedTotal Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , CelecoxibThailand
-
Umraniye Education and Research HospitalNot yet recruiting
-
Zagazig UniversityRecruiting
-
Ain Shams UniversityNot yet recruiting
-
Ain Shams UniversityNot yet recruitingPostoperative Pain, AcuteEgypt
-
Aga Khan UniversityRecruiting
-
Seoul National University HospitalCompletedPostoperative Pain, AcuteKorea, Republic of
-
Huazhong University of Science and TechnologyCompletedPostoperative Pain, Acute
-
Schulthess KlinikNot yet recruiting
-
Seoul National University HospitalNot yet recruiting
Clinical Trials on essencial oil of lavandula angustifolia
-
Scott Hollenbeck, MDdōTERRA InternationalCompletedPain, PostoperativeUnited States
-
University of Sao PauloEnrolling by invitation
-
Qassim UniversityCompleted
-
NYU Langone HealthCompleted
-
University of Southern CaliforniaCompleted
-
Goknur Demir HacimusalarCompletedHemodialysis PatientsTurkey (Türkiye)
-
TC Erciyes UniversityCompletedQuality of Life | Pain | Hemodialysis | Aromatherapy | Muscle CrampsTurkey
-
Wake Forest University Health SciencesCompleted
-
Mayo ClinicCompleted
-
Oregon Health and Science UniversityCompleted